HOMA-S is associated with greater HbAreduction with a GLP-1 analogue in patients with type 2 diabetes

A. H. Heald, R. P. Narayanan, D. Lowes, E. Jarman, E. Onyekwelu, Z. Qureshi, I. Laing, S. G. Anderson

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'HOMA-S is associated with greater HbAreduction with a GLP-1 analogue in patients with type 2 diabetes'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Agricultural and Biological Sciences

    Pharmacology, Toxicology and Pharmaceutical Science